| Bobby Leavorn Etchason, RPH | |
|
1253 Water Tower Pl, Arnold, MO 63010-2142 | |
| (636) 282-0803 | |
| Not Available |
| Full Name | Bobby Leavorn Etchason |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1253 Water Tower Pl, Arnold, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801913611 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 029042 (Missouri) | Primary |
| 183500000X | Pharmacist | (Illinois) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Bobby Leavorn Etchason, RPH 4446 Kerth Circle Xing, Saint Louis, MO 63128-3131 Ph: (314) 892-1792 | Bobby Leavorn Etchason, RPH 1253 Water Tower Pl, Arnold, MO 63010-2142 Ph: (636) 282-0803 |
News Archive
Researchers have discovered signatures in brain activity that allow them to tell old and new memories apart. A team at Japan's RIKEN Center for Brain Science analyzed recordings from mouse brains using a machine-leaning algorithm, which was able to accurately classify memories as recent or remote. They also found robust communication between a frontal brain region and the hippocampus, an area strongly involved in memory formation.
Research into a cancer that is on the rise in the UK is to be presented at the University of Leicester.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $73.2 million for the fourth quarter ended December 31, 2014, a 38% increase compared to $53.1 million in revenue for the same period of 2013. For the fiscal year 2014, the company generated revenue of $278.4 million, a 34% increase compared to revenue of $207.9 million in 2013.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that results from a series of preclinical studies demonstrating that its oncology drug candidate bafetinib inhibits bone destruction in model systems is being presented on April 2, 2011 at the American Academy for Cancer Research 102nd Annual Meeting in Orlando, Florida.
The Los Angeles Times: "Over the next decade, many of [the new health law's] consequences will play out at places like St. Joe's, a 431-bed nonprofit hospital founded by the Sisters of Providence in 1943, and in surrounding community clinics."
› Verified 1 days ago
Mrs. Lynne Marie Ledbetter, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 776 Jeffco Blvd, Arnold, MO 63010 Phone: 636-296-9490 | |
Mark Ivantsov, PHD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 860 Arnold Commons Dr, Arnold, MO 63010 Phone: 636-282-4817 | |
David W Schmiemeier, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3937 Vogel Rd, Arnold, MO 63010 Phone: 636-282-7068 | |
Dr. Luke Neumann, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3900 Vogel Rd, Arnold, MO 63010 Phone: 636-282-7555 | |
Mr. August William Larson Jr., R.PH.,P.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 180 Lamp Post Ln, Arnold, MO 63010 Phone: 636-296-4606 | |
Danielle Marie Evans, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2201 Michigan Ave, Arnold, MO 63010 Phone: 636-282-2657 Fax: 636-282-2847 | |
Rebecca Sander, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3937 Vogel Rd, Arnold, MO 63010 Phone: 636-282-7068 |